Disease Biomarkers in Multiple Sclerosis: Potential for Use in Therapeutic Decision Making

Author： Harris Violaine K.   Sadiq Saud A.  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.13, Iss.4, 2009-08, pp. : 225-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 3, 2011-09 ,pp. : 293-313

Bentham Science Publishers

Access to resources Recommend Favorite

Potential biomarkers in patients with systemic sclerosis

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 1, 2018-01 ,pp. : 261-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of valproic acid and multiple sclerosis

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 3, 2015-03 ,pp. : 262-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Geriatric Assessment for Therapeutic Decision-Making Regarding Renal Replacement in Elderly Patients with Advanced Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

Therapeutic interference with leukocyte recirculation in multiple sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 434-442

John Wiley & Sons Inc

Access to resources Recommend Favorite